Published in Gene Therapy Weekly, June 2nd, 2005
The jointly developed product portfolio is expected to provide complete and validated preanalytical solutions for use in preclinical research and to have full compatibility for use in in-vitro diagnostics (IVD).
The collaboration will combine Epigenomics' technology in methylation analysis capabilities, including DNA bisulfite treatment, with QIAGEN's preanalytical sample preparation technologies in life sciences and molecular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.